PubMed
Nucleotide
Protein
Genome
Structure
PopSet
Taxonomy
OMIM
OMIM Update List for February, 2002
Please send your questions to the
NCBI Help Desk
.
February 28, 2002
New Entries:
606728
SERUM DEPRIVATION RESPONSE PHOSPHATIDYLSERINE-BINDING PROTEIN; SDPR
606729
OXYSTEROL-BINDING PROTEIN 2; OSBP2
606730
OXYSTEROL-BINDING PROTEIN-LIKE PROTEIN 1A; OSBPL1A
606731
OXYSTEROL-BINDING PROTEIN-LIKE PROTEIN 2; OSBPL2
606732
OXYSTEROL-BINDING PROTEIN-LIKE PROTEIN 3; OSBPL3
606733
OXYSTEROL-BINDING PROTEIN-LIKE PROTEIN 5; OSBPL5
606734
OXYSTEROL-BINDING PROTEIN-LIKE PROTEIN 6; OSBPL6
606735
OXYSTEROL-BINDING PROTEIN-LIKE PROTEIN 7; OSBPL7
606736
OXYSTEROL-BINDING PROTEIN-LIKE PROTEIN 8; OSBPL8
606737
OXYSTEROL-BINDING PROTEIN-LIKE PROTEIN 9; OSBPL9
606738
OXYSTEROL-BINDING PROTEIN-LIKE PROTEIN 10; OSBPL10
606739
OXYSTEROL-BINDING PROTEIN-LIKE PROTEIN 11; OSBPL11
Changed Entries:
110700
BLOOD GROUP--DUFFY SYSTEM; FY
120180
COLLAGEN, TYPE III, ALPHA-1; COL3A1
124092
INTERLEUKIN 10; IL10
130050
EHLERS-DANLOS SYNDROME, TYPE IV, AUTOSOMAL DOMINANT; EDS4
137164
GAMMA-AMINOBUTYRIC ACID RECEPTOR, GAMMA-2; GABRG2
141250
HEME OXYGENASE 1; HMOX1
147185
IMMUNOGLOBULIN KAPPA VARIABLE 1/OR2-108; IGKV1OR2108
173470
INTEGRIN, BETA-3; ITGB3
176943
FIBROBLAST GROWTH FACTOR RECEPTOR 2; FGFR2
188540
THYROID-STIMULATING HORMONE, BETA CHAIN; TSHB
188550
THYROID CARCINOMA, PAPILLARY
191160
TUMOR NECROSIS FACTOR; TNF
215700
CITRULLINEMIA, CLASSIC
222600
DIASTROPHIC DYSPLASIA
273800
THROMBASTHENIA OF GLANZMANN AND NAEGELI
308230
IMMUNODEFICIENCY WITH HYPER-IgM
601407
DIABETES MELLITUS, NONINSULIN-DEPENDENT, 2; NIDDM2
603384
SYNAPTIC RAS-GTPase-ACTIVATING PROTEIN 1; SYNGAP1
606718
SOLUTE CARRIER FAMILY 26, MEMBER 2; SLC26A2
606728
SERUM DEPRIVATION RESPONSE PHOSPHATIDYLSERINE-BINDING PROTEIN; SDPR
606729
OXYSTEROL-BINDING PROTEIN 2; OSBP2
606730
OXYSTEROL-BINDING PROTEIN-LIKE PROTEIN 1A; OSBPL1A
February 27, 2002
New Entries:
606718
SOLUTE CARRIER FAMILY 26, MEMBER 2; SLC26A2
606722
NEUROCALCIN, DELTA; NCALD
606724
MITOGEN-ACTIVATED PROTEIN KINASE-INTERACTING SERINE/THREONINE KINASE
606725
CLN6 GENE; CLN6
606726
SOLUTE CARRIER FAMILY 12, MEMBER 5; SLC12A5
606727
NK2, DROSOPHILA, HOMOLOG OF, C; NKX2C
Clinical Synopsis for
602579
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE Ib
Clinical Synopsis for
603147
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE Ic
Clinical Synopsis for
603585
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE Ix
Changed Entries:
102670
MUCOSAL VASCULAR ADDRESSIN CELL ADHESION MOLECULE 1; MADCAM1
103900
HYPERALDOSTERONISM, FAMILIAL, TYPE I
107910
CYTOCHROME P450, SUBFAMILY XIX; CYP19
118485
CYTOCHROME P450, SUBFAMILY XIA; CYP11A
119800
CLUBFOOT
133440
EUKARYOTIC TRANSLATION INITIATION FACTOR 4E; EIF4E
142622
HIPPOCALCIN; HPCA
154500
TREACHER COLLINS-FRANCESCHETTI SYNDROME 1; TCOF1
161561
INTERLEUKIN 12B; IL12B
176761
PROLACTIN RECEPTOR; PRLR
176948
MITOGEN-ACTIVATED PROTEIN KINASE 1; MAPK1
182455
SOMATOSTATIN RECEPTOR 5; SSTR5
188470
THYROID CARCINOMA, FOLLICULAR; FTC
201710
LIPOID CONGENITAL ADRENAL HYPERPLASIA
204500
CEROID LIPOFUSCINOSIS, NEURONAL 2, LATE INFANTILE TYPE; CLN2
222600
DIASTROPHIC DYSPLASIA
226900
EPIPHYSEAL DYSPLASIA, MULTIPLE, 4; EDM4
251450
MICROMELIC DWARFISM WITH VERTEBRAL AND METAPHYSEAL ABNORMALITIES AND
256050
NEONATAL OSSEOUS DYSPLASIA I
475000
GROWTH CONTROL, Y-CHROMOSOME INFLUENCED; GCY
600207
HIPPOCALCIN-LIKE 1; HPCAL1
600354
SURVIVAL OF MOTOR NEURON 1, TELOMERIC; SMN1
600495
EUKARYOTIC TRANSLATION INITIATION FACTOR 4-GAMMA, 1; EIF4G1
600837
GLIAL CELL LINE-DERIVED NEUROTROPHIC FACTOR; GDNF
600972
ACHONDROGENESIS, TYPE IB; ACG1B
601627
SURVIVAL OF MOTOR NEURON 2, CENTROMERIC; SMN2
601780
CEROID LIPOFUSCINOSIS, NEURONAL, LATE-INFANTILE, VARIANT
601795
MITOGEN-ACTIVATED PROTEIN KINASE 3; MAPK3
602325
EUKARYOTIC TRANSLATION INITIATION FACTOR 4-GAMMA, 2; EIF4G2
602579
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE Ib
603005
3-PRIME-@PHOSPHOADENOSINE 5-PRIME-PHOSPHOSULFATE SYNTHASE 2; PAPSS2
603147
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE Ic
603585
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE Ix
604309
SOLUTE CARRIER FAMILY 13, MEMBER 4; SLC13A4
605069
G PROTEIN-COUPLED RECEPTOR KINASE 7; GPRK7
605646
SOLUTE CARRIER FAMILY 26, MEMBER 4; SLC26A4
606193
SOLUTE CARRIER FAMILY 13, MEMBER 1; SLC13A1
606227
MEMBRANE-TYPE FRIZZLED-RELATED PROTEIN; MFRP
606719
MELANOMA-PANCREATIC CANCER SYNDROME
606722
NEUROCALCIN, DELTA; NCALD
606723
MITOGEN-ACTIVATED PROTEIN KINASE-ACTIVATED PROTEIN KINASE 5; MAPKAPK5
Clinical Synopsis for
203450
ALEXANDER DISEASE
Clinical Synopsis for
209900
BARDET-BIEDL SYNDROME; BBS
Clinical Synopsis for
212065
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE Ia
Clinical Synopsis for
236700
MCKUSICK-KAUFMAN SYNDROME; MKKS
Clinical Synopsis for
249000
MECKEL SYNDROME, TYPE 1; MKS1
Clinical Synopsis for
603147
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE Ic
February 26, 2002
New Entries:
300379
PUTATIVE RING ZINC FINGER PROTEIN NY-REN-43 ANTIGEN
300380
CYTIDINE 5-PRIME TRIPHOSPHATE SYNTHETASE 2; CTPS2
606608
YES-ASSOCIATED PROTEIN 1, 65-KD; YAP1
606719
MELANOMA-PANCREATIC CANCER SYNDROME
606721
LIPODYSTROPHY WITH CONGENITAL CATARACTS AND NEURODEGENERATION
606723
MITOGEN-ACTIVATED PROTEIN KINASE-ACTIVATED PROTEIN KINASE 5; MAPKAPK5
Changed Entries:
122500
CORTICOSTEROID-BINDING GLOBULIN; CBG
124080
CYTOCHROME P450, SUBFAMILY XIB, POLYPEPTIDE 2; CYP11B2
125853
DIABETES MELLITUS, NONINSULIN-DEPENDENT; NIDDM
131100
MULTIPLE ENDOCRINE NEOPLASIA, TYPE I; MEN1
186930
T-CELL ANTIGEN RECEPTOR, BETA SUBUNIT; TCRB
202010
ADRENAL HYPERPLASIA, CONGENITAL, DUE TO 11-@BETA-HYDROXYLASE DEFICIENCY
260350
PANCREATIC CARCINOMA
600160
CYCLIN-DEPENDENT KINASE INHIBITOR 2A; CDKN2A
600289
MITOGEN-ACTIVATED PROTEIN KINASE 14; MAPK14
600630
UV-SENSITIVE SYNDROME; UVS
602195
HEAT-SHOCK 27-KD PROTEIN 1; HSPB1
603471
CITRULLINEMIA, TYPE II, ADULT-ONSET; CTLN2
603859
SOLUTE CARRIER FAMILY 25, MEMBER 13; SLC25A13
604751
ZINC FINGER PROTEIN 266; ZNF266
604752
ZINC FINGER PROTEIN 267; ZNF267
605504
KALLIKREIN 9; KLK9
605814
CITRULLINEMIA, TYPE II, NEONATAL-ONSET
606655
LEUCINE-RICH REPEAT-CONTAINING G PROTEIN-COUPLED RECEPTOR 8
606716
N-ACETYLTRANSFERASE 8; NAT8
606719
MELANOMA-PANCREATIC CANCER SYNDROME
606721
LIPODYSTROPHY WITH CONGENITAL CATARACTS AND NEURODEGENERATION
Clinical Synopsis for
209900
BARDET-BIEDL SYNDROME; BBS
Clinical Synopsis for
236700
MCKUSICK-KAUFMAN SYNDROME; MKKS
February 25, 2002
New Entries:
300378
RADIAL RAY DEFICIENCY, X-LINKED
606710
LIPOMA HMGIC FUSION PARTNER; LHFP
606711
SPECIFIC LANGUAGE IMPAIRMENT QUANTITATIVE TRAIT LOCUS ON CHROMOSOME
606712
SPECIFIC LANGUAGE IMPAIRMENT QUANTITATIVE TRAIT LOCUS ON CHROMOSOME
606713
VAN DER WOUDE SYNDROME 2
606714
PROLINE-RICH 2; PROL2
606715
ACID-SENSING ION CHANNEL 4
606716
N-ACETYLTRANSFERASE 8; NAT8
606717
XIAP-ASSOCIATED FACTOR 1
Changed Entries:
118800
PAROXYSMAL NONKINESIGENIC DYSKINESIA; PNKD
119300
VAN DER WOUDE SYNDROME; VWS
120150
COLLAGEN, TYPE I, ALPHA-1; COL1A1
142410
TRANSCRIPTION FACTOR 1; TCF1
187300
TELANGIECTASIA, HEREDITARY HEMORRHAGIC, OF RENDU, OSLER, AND WEBER;
209850
AUTISM, SUSCEPTIBILITY TO, 1; AUTS1
222100
DIABETES MELLITUS, INSULIN-DEPENDENT; IDDM
252900
MUCOPOLYSACCHARIDOSIS TYPE IIIA
252920
MUCOPOLYSACCHARIDOSIS TYPE IIIB
253200
MUCOPOLYSACCHARIDOSIS TYPE VI
600374
BBS4 GENE; BBS4
600698
HIGH MOBILITY GROUP PROTEIN ISOFORM I-C; HMGIC
601767
HUNTINGTIN-INTERACTING PROTEIN 1; HIP1
602081
SPECIFIC LANGUAGE IMPAIRMENT; SLI
603315
FREQUENIN, DROSOPHILA, HOMOLOG OF; FREQ
604999
SH3 AND MULTIPLE ANKYRIN REPEAT DOMAINS 1; SHANK1
605270
N-SULFOGLUCOSAMINE SULFOHYDROLASE; SGSH
606650
GLUTAMATE RECEPTOR, IONOTROPIC, N-METHYL-D-ASPARTATE 3A; GRIN3A
606651
GLUTAMATE RECEPTOR, IONOTROPIC, N-METHYL-D-ASPARTATE 3B; GRIN3B
606716
N-ACETYLTRANSFERASE 8; NAT8
Clinical Synopsis for
600374
BBS4 GENE; BBS4
February 25, 2002
Changed Entries:
134638
TUMOR NECROSIS FACTOR LIGAND SUPERFAMILY, MEMBER 6; TNFSF6
181750
SCLERODERMA, FAMILIAL PROGRESSIVE
238310
AMINOMETHYLTRANSFERASE; AMT
238330
GLYCINE CLEAVAGE SYSTEM H PROTEIN; GCSH
310400
MYOTUBULAR MYOPATHY 1; MTM1
600259
POSTMEIOTIC SEGREGATION INCREASED, S. CEREVISIAE, 2; PMS2
603598
TUMOR NECROSIS FACTOR LIGAND SUPERFAMILY, MEMBER 10; TNFSF10
February 22, 2002
New Entries:
606709
PROTEASE, SERINE, 12; PRSS12
Changed Entries:
104760
AMYLOID BETA A4 PRECURSOR PROTEIN; APP
109770
CARCINOEMBRYONIC ANTIGEN-RELATED CELL ADHESION MOLECULE 1; CEACAM1
116845
CATHEPSIN S; CTSS
137360
GENOCHONDROMATOSIS
142790
CD74 ANTIGEN; CD74
142960
HOMEO BOX B5; HOXB5
147250
SOLITARY MEDIAN MAXILLARY CENTRAL INCISOR; SMMCI
148030
KERATIN 15; KRT15
148040
KERATIN 5; KRT5
148066
KERATIN 14; KRT14
161200
NAIL-PATELLA SYNDROME; NPS
164210
HEMIFACIAL MICROSOMIA; HFM
164785
MOUSE DOUBLE MINUTE 2 HOMOLOG; MDM2
166000
ENCHONDROMATOSIS, MULTIPLE
166300
OSTEOLYSIS, HEREDITARY, OF CARPAL BONES WITH NEPHROPATHY
168468
PARATHYROID HORMONE RECEPTOR 1; PTHR1
179520
RAS-RELATED PROTEIN 1A; RAP1A
187011
SMALL INDUCIBLE CYTOKINE A5; SCYA5
188410
THYMOCYTE ANTIGEN CD1D; CD1D
225795
MOVED TO 166000
238300
GLYCINE DECARBOXYLASE; GLDC
256730
CEROID LIPOFUSCINOSIS, NEURONAL 1, INFANTILE; CLN1
300500
ALBINISM, OCULAR, TYPE I; OA1
311250
ORNITHINE TRANSCARBAMYLASE DEFICIENCY, HYPERAMMONEMIA DUE TO; OTC
600483
FIBROBLAST GROWTH FACTOR 8; FGF8
600508
NCK ADAPTOR PROTEIN 1; NCK1
600805
LAMININ, ALPHA-3; LAMA3
601664
U5 snRNP-SPECIFIC PROTEIN, 200-KD
603177
VESICLE-ASSOCIATED MEMBRANE PROTEIN 8; VAMP8
603288
KERATOCAN; KERA
604520
TUMOR NECROSIS FACTOR LIGAND SUPERFAMILY, MEMBER 14; TNFSF14
604895
T-BOX 21; TBX21
604978
CLEAVAGE AND POLYADENYLATION SPECIFICITY FACTOR 5; CPSF5
605171
p53-INDUCED GENE 3
605369
AIRWAY TRYPSIN-LIKE PROTEASE
605658
INTERLEUKIN 17E; IL17E
605899
GLYCINE ENCEPHALOPATHY; GCE
606706
TRANSMEMBRANE COCHLEAR-EXPRESSED GENE 1; TMC1
606708
SPLIT-HAND/FOOT MALFORMATION 5
606709
PROTEASE, SERINE, 12; PRSS12
February 21, 2002
New Entries:
300375
CARBOHYDRATE SULFOTRANSFERASE 7; CHST7
606702
POLYCYSTIC KIDNEY AND HEPATIC DISEASE 1 GENE; PKHD1
606703
DYSKINESIA, FAMILIAL, WITH FACIAL MYOKYMIA
606704
G PROTEIN-COUPLED RECEPTOR 75; GPR75
606705
DEAFNESS, AUTOSOMAL DOMINANT NONSYNDROMIC SENSORINEURAL 36; DFNA36
606706
TRANSMEMBRANE COCHLEAR-EXPRESSED GENE 1; TMC1
606707
TRANSMEMBRANE COCHLEAR-EXPRESSED GENE 2; TMC2
606708
SPLIT-HAND/FOOT MALFORMATION 5
Changed Entries:
118700
CHOREA, HEREDITARY BENIGN; BCH
125647
DESMOPLAKIN; DSP
133171
ERYTHROPOIETIN RECEPTOR; EPOR
142830
MAJOR HISTOCOMPATIBILITY COMPLEX, CLASS I, B; HLA-B
142857
MAJOR HISTOCOMPATIBILITY COMPLEX, CLASS II, DR BETA-1; HLA-DRB1
154870
GAMMA-CARBOXYGLUTAMIC ACID PROTEIN, MATRIX; MGP
168820
PARAOXONASE 1; PON1
183600
SPLIT-HAND/FOOT MALFORMATION 1; SHFM1
186000
SYNDACTYLY, TYPE II
191315
NEUROTROPHIC TYROSINE KINASE, RECEPTOR, TYPE 1; NTRK1
204400
REMOVED FROM DATABASE
209850
AUTISTIC DISORDER
213000
CEREBELLAR HYPOPLASIA
213200
CEREBELLAR ATAXIA 1; CLA1
254800
MYOCLONIC EPILEPSY OF UNVERRICHT AND LUNDBORG
263200
POLYCYSTIC KIDNEY DISEASE, AUTOSOMAL RECESSIVE; ARPKD
301000
WISKOTT-ALDRICH SYNDROME; WAS
308230
IMMUNODEFICIENCY WITH HYPER-IgM
313350
SPLIT-HAND/FOOT MALFORMATION 2; SHFM2
313700
ANDROGEN RECEPTOR; AR
600046
ATP-BINDING CASSETTE, SUBFAMILY A, MEMBER 1; ABCA1
600095
SPLIT-HAND/FOOT MALFORMATION 3; SHFM3
600173
JANUS KINASE 3; JAK3
600974
DEAFNESS, NEUROSENSORY, AUTOSOMAL RECESSIVE 7; DFNB7
601908
G PROTEIN-COUPLED RECEPTOR 20; GPR20
603273
TUMOR PROTEIN p63
603499
TUMOR NECROSIS FACTOR RECEPTOR SUPERFAMILY, MEMBER 11A; TNFRSF11A
603799
CARBOHYDRATE SULFOTRANSFERASE 3; CHST3
604221
ACTIN-RELATED PROTEIN 2; ACTR2
605035
WISKOTT-ALDRICH SYNDROME PROTEIN FAMILY, MEMBER 1; WASF1
605257
ACTIVATION-INDUCED CYTIDINE DEAMINASE; AICDA
605289
SPLIT-HAND/FOOT MALFORMATION 4; SHFM4
606265
E1A-BINDING PROTEIN, 400-KD; EP400
606700
MIDNOLIN, MOUSE, HOMOLOG OF; MIDN
606703
DYSKINESIA, FAMILIAL, WITH FACIAL MYOKYMIA
606704
G PROTEIN-COUPLED RECEPTOR 75; GPR75
606706
TRANSMEMBRANE COCHLEAR-EXPRESSED GENE 1; TMC1
606708
SPLIT-HAND/FOOT MALFORMATION 5
Clinical Synopsis for
204400
REMOVED FROM DATABASE
February 20, 2002
New Entries:
606698
SRY-BOX 30
606699
HELICASE WITH ZINC FINGER DOMAIN; HELZ
606700
MIDNOLIN, MOUSE, HOMOLOG OF; MIDN
606701
DRG11, RAT, HOMOLOG OF
Changed Entries:
107265
CD19 ANTIGEN; CD19
107470
INTERFERON, GAMMA, RECEPTOR 1; IFNGR1
136530
FOLLICLE-STIMULATING HORMONE, BETA POLYPEPTIDE; FSHB
138130
GLUTAMATE DEHYDROGENASE 1; GLUD1
139191
GROWTH HORMONE-RELEASING HORMONE RECEPTOR; GHRHR
139250
GROWTH HORMONE 1; GH1
143890
HYPERCHOLESTEROLEMIA, FAMILIAL
146732
INSULIN-LIKE GROWTH FACTOR-BINDING PROTEIN 3; IGFBP3
156240
MESOTHELIOMA, MALIGNANT
159555
MYELOID/LYMPHOID OR MIXED LINEAGE LEUKEMIA; MLL
165120
V-YES-1 YAMAGUCHI SARCOMA VIRAL RELATED ONCOGENE HOMOLOG; LYN
177020
PROTEINASE 3; PRTN3
182115
PLECKSTRIN HOMOLOGY, SEC7, AND COILED-COIL DOMAINS PROTEIN 1; PSCD1
193400
VON WILLEBRAND DISEASE
209950
ATYPICAL MYCOBACTERIOSIS, FAMILIAL
222600
DIASTROPHIC DYSPLASIA
266600
INFLAMMATORY BOWEL DISEASE 1; IBD1
314200
THYROXINE-BINDING GLOBULIN OF SERUM; TBG
600953
INTERLEUKIN 18; IL18
601487
PEROXISOME PROLIFERATOR-ACTIVATED RECEPTOR-GAMMA; PPARG
603827
BCL2-LIKE 11; BCL2L11
605268
JUNCTOPHILIN 3; JPH3
605598
DIABETES MELLITUS, INSULIN-DEPENDENT, 18; IDDM18
605987
PROTEIN INHIBITOR OF ACTIVATED STAT3
606592
VANIN 3; VNN3
606697
ZINC FINGER PROTEIN ZK1
606698
SRY-BOX 30
606699
HELICASE WITH ZINC FINGER DOMAIN; HELZ
Clinical Synopsis for
212065
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE Ia
Clinical Synopsis for
248700
MARDEN-WALKER SYNDROME
Clinical Synopsis for
269150
SCHINZEL-GIEDION MIDFACE-RETRACTION SYNDROME
Clinical Synopsis for
276700
TYROSINEMIA, TYPE I
February 19, 2002
New Entries:
606697
ZINC FINGER PROTEIN ZK1
Changed Entries:
103275
ADRENOMEDULLIN; ADM
107470
INTERFERON, GAMMA, RECEPTOR 1; IFNGR1
114190
CALCITONIN RECEPTOR-LIKE GENE; CALCRL
125850
MATURITY-ONSET DIABETES OF THE YOUNG, TYPE I; MODY1
143850
ORTHOSTATIC HYPOTENSIVE DISORDER, STREETEN TYPE
160900
DYSTROPHIA MYOTONICA 1
161560
INTERLEUKIN 12A; IL12A
161561
INTERLEUKIN 12B; IL12B
168860
PATELLA APLASIA-HYPOPLASIA; PTLAH
171300
PHEOCHROMOCYTOMA
175100
ADENOMATOUS POLYPOSIS OF THE COLON; APC
204200
CEROID LIPOFUSCINOSIS, NEURONAL 3, JUVENILE; CLN3
218040
COSTELLO SYNDROME
227400
FACTOR V DEFICIENCY
229300
FRIEDREICH ATAXIA 1; FRDA
248300
MAL DE MELEDA
300248
INHIBITOR OF KAPPA LIGHT POLYPEPTIDE GENE ENHANCER IN B CELLS, KINASE
308300
INCONTINENTIA PIGMENTI; IP
314200
THYROXINE-BINDING GLOBULIN OF SERUM; TBG
600044
THROMBOPOIETIN; THPO
600160
CYCLIN-DEPENDENT KINASE INHIBITOR 2A; CDKN2A
600281
HEPATOCYTE NUCLEAR FACTOR 4-ALPHA; HNF4A
601224
POTOCKI-SHAFFER SYNDROME
601417
17-@BETA-HYDROXYSTEROID DEHYDROGENASE VIII; HSD17B8
601611
SOLUTE CARRIER FAMILY 14, MEMBER 2; SLC14A2
602668
DYSTROPHIA MYOTONICA 2; DM2
602671
GLUCOSE-6-PHOSPHATE TRANSPORTER 1; G6PT1
602703
KATANIN, p80 SUBUNIT, B1; KATNB1
602858
7-@DEHYDROCHOLESTEROL REDUCTASE; DHCR7
603101
CARBOXYPEPTIDASE B2, PLASMA; CPB2
603171
NEURAL PRECURSOR CELL EXPRESSED, DEVELOPMENTALLY DOWNREGULATED 8;
603945
EUKARYOTIC TRANSLATION INITIATION FACTOR 2B, SUBUNIT 5; EIF2B5
604396
SET DOMAIN PROTEIN, BIFURCATED, 1; SETDB1
604687
PROSTAGLANDIN D2 RECEPTOR; PTGDR
604837
G PROTEIN-COUPLED RECEPTOR 44; GPR44
605154
RECEPTOR ACTIVITY-MODIFYING PROTEIN 2; RAMP2
605307
ADRENOMEDULLIN RECEPTOR; ADMR
605821
ERYTHROID-ASSOCIATED FACTOR; ERAF
606454
EUKARYOTIC TRANSLATION INITIATION FACTOR 2B, SUBUNIT 2; EIF2B2
606516
MUSCLEBLIND-LIKE PROTEIN; MBNL
Clinical Synopsis for
114290
CAMPOMELIC DYSPLASIA
Clinical Synopsis for
230400
GALACTOSEMIA
Clinical Synopsis for
247200
MILLER-DIEKER LISSENCEPHALY SYNDROME; MDLS
Clinical Synopsis for
276700
TYROSINEMIA, TYPE I
February 19, 2002
New Entries:
606592
VANIN 3; VNN3
606612
MUSCULAR DYSTROPHY, CONGENITAL, 1C; MDC1C
606694
NUCLEOPORIN, 155-KD; NUP155
606695
OPSIN 3; OPN3
606696
KATANIN, p60 SUBUNIT, A1; KATNA1
Changed Entries:
100730
CHOLINERGIC RECEPTOR, NICOTINIC, GAMMA POLYPEPTIDE; CHRNG
106210
PAIRED BOX GENE 6; PAX6
118220
CHARCOT-MARIE-TOOTH DISEASE, TYPE 1A; CMT1A
118825
CHOROIDEREMIA-LIKE; CHML
126452
DOPAMINE RECEPTOR D4; DRD4
144110
HYPERHIDROSIS PALMARIS ET PLANTARIS
146880
MAJOR HISTOCOMPATIBILITY COMPLEX, CLASS II, DQ ALPHA-1; HLA-DQA1
147450
SUPEROXIDE DISMUTASE 1; SOD1
153700
MACULAR DYSTROPHY, VITELLIFORM; VMD2
176730
INSULIN; INS
180849
RUBINSTEIN SYNDROME
191050
TRYPTOPHANYL-tRNA SYNTHETASE; WARS
200990
ACROCALLOSAL SYNDROME; ACLS
201475
ACYL-CoA DEHYDROGENASE, VERY LONG-CHAIN, DEFICIENCY OF
209900
BARDET-BIEDL SYNDROME; BBS
214500
CHEDIAK-HIGASHI SYNDROME; CHS1
222100
DIABETES MELLITUS, INSULIN-DEPENDENT; IDDM
225790
ENCEPHALOCLASTIC PROLIFERATIVE VASCULOPATHY; EPV
227650
FANCONI ANEMIA, COMPLEMENTATION GROUP A; FANCA
232300
GLYCOGEN STORAGE DISEASE II
235200
HEMOCHROMATOSIS; HFE
236200
HOMOCYSTINURIA
242860
IMMUNODEFICIENCY-CENTROMERIC INSTABILITY-FACIAL ANOMALIES SYNDROME
268100
ENHANCED S-CONE SYNDROME; ESCS
277900
WILSON DISEASE
300079
BACULOVIRAL IAP REPEAT-CONTAINING PROTEIN 4; BIRC4
300181
X INACTIVATION-SPECIFIC TRANSCRIPT-ANTISENSE; TSIX
301040
ALPHA-THALASSEMIA/MENTAL RETARDATION SYNDROME, X-LINKED; ATRX
303600
COFFIN-LOWRY SYNDROME; CLS
308840
L1 CELL ADHESION MOLECULE; L1CAM
312750
RETT SYNDROME; RTT
314670
X INACTIVATION-SPECIFIC TRANSCRIPT; XIST
600289
MITOGEN-ACTIVATED PROTEIN KINASE 14; MAPK14
600424
SOLUTE CARRIER FAMILY 19, MEMBER 1; SLC19A1
600442
AQUAPORIN 5; AQP5
600597
PHOSPHOLIPASE C-LIKE 1; PLCL1
600725
SONIC HEDGEHOG; SHH
601097
PERIPHERAL MYELIN PROTEIN 22; PMP22
601283
DIABETES MELLITUS, NONINSULIN-DEPENDENT, 1; NIDDM1
601556
ATAXIN 1; ATX1
601618
SRY-BOX 18; SOX18
602386
ZINC FINGER PROTEIN 212; ZNF212
602615
TAK1-BINDING PROTEIN 1
602703
KATANIN, p80 SUBUNIT, B1; KATNB1
603171
NEURAL PRECURSOR CELL EXPRESSED, DEVELOPMENTALLY DOWNREGULATED 8;
603538
KYNURENINE 3-MONOOXYGENASE; KMO
603570
VANIN 1; VNN1
603948
NUCLEOPORIN, 153-KD; NUP153
603972
ZINC FINGER PROTEIN 43; ZNF43
604290
ACERULOPLASMINEMIA
604485
NUCLEAR RECEPTOR SUBFAMILY 2, GROUP E, MEMBER 3; NR2E3
604748
SRY-BOX 13; SOX13
604975
SRY-BOX 5; SOX5
605286
CALPAIN 10; CAPN10
606592
VANIN 3; VNN3
606618
DUAL-SPECIFICITY PHOSPHATASE 14; DUSP14
606620
B-LYMPHOCYTE ACTIVATOR, MACROPHAGE-EXPRESSED
606696
KATANIN, p60 SUBUNIT, A1; KATNA1
February 16, 2002
Changed Entries:
603948
NUCLEOPORIN, 153-KD; NUP153
604646
NUCLEOPORIN, 50-KD; NUP50
605815
NUCLEOPORIN, 62-KD; NUP62
February 15, 2002
New Entries:
606693
PALLIDOPYRAMIDAL DEGENERATION WITH SUPRANUCLEAR UPGAZE PARESIS AND
Changed Entries:
137760
GLAUCOMA, PRIMARY OPEN ANGLE, ADULT-ONSET; POAG
146710
INTERLEUKIN 2 RECEPTOR, BETA; IL2RB
147680
INTERLEUKIN 2; IL2
147730
INTERLEUKIN 2 RECEPTOR, ALPHA; IL2RA
158120
MONOCYTE DIFFERENTIATION ANTIGEN CD14; CD14
168820
PARAOXONASE 1; PON1
171790
PHOSPHATASE, PROSTATE-SPECIFIC ACID; ACPP
211600
CHOLESTASIS, PROGRESSIVE FAMILIAL INTRAHEPATIC 1; PFIC1
226650
EPIDERMOLYSIS BULLOSA JUNCTIONALIS, DISENTIS TYPE
300292
FORKHEAD BOX P3
308380
INTERLEUKIN 2 RECEPTOR, GAMMA; IL2RG
600805
LAMININ, ALPHA-3; LAMA3
600832
ACIDIC LEUCINE-RICH NUCLEAR PHOSPHOPROTEIN 32 FAMILY, MEMBER A; ANP32A
601265
NODAL, MOUSE, HOMOLOG OF; NODAL
602033
ECHINODERM MICROTUBULE-ASSOCIATED PROTEIN-LIKE 1; EML1
602397
ATPase, CLASS I, TYPE 8B, MEMBER 1; ATP8B1
602552
NUCLEOPORIN, 88-KD; NUP88
602695
TUMOR NECROSIS FACTOR LIGAND SUPERFAMILY, MEMBER 12; TNFSF12
603527
DIPHTHAMIDE BIOSYNTHESIS PROTEIN 2, S. CEREVISIAE, HOMOLOG-LIKE 1;
604740
SOLUTE CARRIER FAMILY 39, ZINC TRANSPORTER, MEMBER 1; SLC39A1
605815
NUCLEOPORIN, 62-KD; NUP62
605914
TYPE I TRANSMEMBRANE PROTEIN FN14
606178
HEDGEHOG-INTERACTING PROTEIN; HHIP
606265
TRINUCLEOTIDE REPEAT-CONTAINING GENE 12; TNRC12
606273
EUKARYOTIC TRANSLATION INITIATION FACTOR 2B, SUBUNIT 3; EIF2B3
606655
GLYCOPROTEIN HORMONE, ALPHA-2; GPHA2
606677
LECTIN, C-TYPE, SUPERFAMILY MEMBER 11; CLECSF11
606693
PALLIDOPYRAMIDAL DEGENERATION WITH SUPRANUCLEAR UPGAZE PARESIS AND
February 14, 2002
New Entries:
606690
LYMPHANGIOLEIOMYOMATOSIS; LAM
Clinical Synopsis for
606688
PRION DISEASE WITH PROTRACTED COURSE
Changed Entries:
107400
PROTEASE INHIBITOR 1; PI
118955
CLATHRIN, HEAVY POLYPEPTIDE; CLTC
137760
GLAUCOMA, PRIMARY OPEN ANGLE, ADULT-ONSET; POAG
143100
HUNTINGTON DISEASE; HD
164160
LEPTIN; LEP
176270
PRADER-WILLI SYNDROME; PWS
176640
PRION PROTEIN; PRNP
181430
SCAPULOPERONEAL MYOPATHY; SPM
185800
SYMPHALANGISM, PROXIMAL; SYM1
191092
TUBEROUS SCLEROSIS 2 GENE; TSC2
191290
TYROSINE HYDROXYLASE; TH
192430
VELOCARDIOFACIAL SYNDROME
202110
ADRENAL HYPERPLASIA, CONGENITAL, DUE TO 17-ALPHA-HYDROXYLASE DEFICIENCY
235200
HEMOCHROMATOSIS; HFE
254800
MYOCLONIC EPILEPSY OF UNVERRICHT AND LUNDBORG
261600
PHENYLKETONURIA
300017
FILAMIN A; FLNA
309550
FRAGILE SITE MENTAL RETARDATION 1; FMR1
600119
SARCOGLYCAN, ALPHA; SGCA
600242
CHEMOKINE (C-C) RECEPTOR 7; CCR7
600702
SODIUM CHANNEL, VOLTAGE-GATED, TYPE VIII, ALPHA SUBUNIT; SCN8A
600797
INSULIN RECEPTOR SUBSTRATE 2; IRS2
601007
LEPTIN RECEPTOR; LEPR
601026
ADAPTOR-RELATED PROTEIN COMPLEX 2, ALPHA-1 SUBUNIT; AP2A1
601145
CYSTATIN B; CSTB
601628
MODIFIER OF VON WILLEBRAND FACTOR
601767
HUNTINGTIN-INTERACTING PROTEIN 1; HIP1
602421
CYSTIC FIBROSIS TRANSMEMBRANE CONDUCTANCE REGULATOR; CFTR
602432
OPTINEURIN; OPTN
602737
SMALL INDUCIBLE CYTOKINE SUBFAMILY A, MEMBER 21; SCYA21
602768
DELTA-LIKE 3; DLL3
602991
NOGGIN, MOUSE, HOMOLOG OF; NOG
603803
DACHSHUND, DROSOPHILA, HOMOLOG OF; DACH
604592
T CELL IMMUNE REGULATOR 1; TCIRG1
604655
MITOGEN-ACTIVATED PROTEIN KINASE KINASE KINASE 14; MAP3K14
604862
LECTIN, C-TYPE, LANGERHANS CELL-SPECIFIC
605284
TUBEROUS SCLEROSIS 1 GENE; TSC1
606688
PRION DISEASE WITH PROTRACTED COURSE
Clinical Synopsis for
176640
PRION PROTEIN; PRNP
Clinical Synopsis for
191092
TUBEROUS SCLEROSIS 2 GENE; TSC2
Clinical Synopsis for
191100
TUBEROUS SCLEROSIS; TS
February 13, 2002
New Entries:
606688
PRION DISEASE WITH PROTRACTED COURSE
606689
GLAUCOMA 1, OPEN ANGLE, B; GLC1B
Changed Entries:
106150
ANGIOTENSIN I; AGT
135630
INTEGRIN, BETA-1; ITGB1
137440
GERSTMANN-STRAUSSLER DISEASE; GSD
137750
GLAUCOMA, PRIMARY OPEN ANGLE, JUVENILE-ONSET; JOAG
137760
GLAUCOMA, PRIMARY OPEN ANGLE, ADULT-ONSET; POAG
147280
INSULIN-LIKE GROWTH FACTOR 2 RECEPTOR; IGF2R
147450
SUPEROXIDE DISMUTASE 1; SOD1
147557
INTEGRIN, BETA-4; ITGB4
170998
PEROXISOME PROLIFERATOR-ACTIVATED RECEPTOR-ALPHA; PPARA
171050
ATP-BINDING CASSETTE, SUBFAMILY B, MEMBER 1; ABCB1
176640
PRION PROTEIN; PRNP
188340
THYMOCYTE ANTIGEN CD1C; CD1C
188360
THYMOCYTE ANTIGEN CD1B; CD1B
188370
THYMOCYTE ANTIGEN CD1A; CD1A
188410
THYMOCYTE ANTIGEN CD1D; CD1D
188411
THYMOCYTE ANTIGEN CD1E; CD1E
248600
MAPLE SYRUP URINE DISEASE, TYPE IA
256550
NEURAMINIDASE DEFICIENCY
276700
TYROSINEMIA, TYPE I
300005
METHYL-CpG-BINDING PROTEIN 2; MECP2
601253
CAVEOLIN 3; CAV3
601652
MYOCILIN; MYOC
601682
GLAUCOMA 1, OPEN ANGLE, C; GLC1C
602429
GLAUCOMA 1, OPEN ANGLE, D; GLC1D
602432
OPTINEURIN; OPTN
602575
LIM HOMEO BOX TRANSCRIPTION FACTOR 1, BETA; LMX1B
602608
SOLUTE CARRIER FAMILY 22, MEMBER 2; SLC22A2
602851
VERY LARGE G PROTEIN-COUPLED RECEPTOR 1
603009
DYSFERLIN; DYSF
603797
CARBOHYDRATE SULFOTRANSFERASE 1; CHST1
603799
CARBOHYDRATE SULFOTRANSFERASE 3; CHST3
604842
SOLUTE CARRIER FAMILY 22, MEMBER 3; SLC22A3
604893
ANTISENSE IGF2R
605264
SH3 DOMAIN PROTEIN 5; SH3D5
606118
HERMANSKY-PUDLAK SYNDROME GENE 3; HPS3
606657
GLAUCOMA, NORMAL TENSION, SUSCEPTIBILITY TO
606683
FXYD DOMAIN-CONTAINING ION TRANSPORT REGULATOR 6; FXYD6
606684
FXYD DOMAIN-CONTAINING ION TRANSPORT REGULATOR 7; FXYD7
Clinical Synopsis for
170998
PEROXISOME PROLIFERATOR-ACTIVATED RECEPTOR-ALPHA; PPARA
February 12, 2002
New Entries:
606685
CARDIOMYOPATHY, DILATED, 1L; CMD1L
606686
EUKARYOTIC TRANSLATION INITIATION FACTOR 2B, SUBUNIT 1; EIF2B1
606687
EUKARYOTIC TRANSLATION INITIATION FACTOR 2B, SUBUNIT 4; EIF2B4
Changed Entries:
102578
ACUTE PROMYELOCYTIC LEUKEMIA, INDUCER OF; PML
104175
GLYCOPROTEIN ALPHA-GALACTOSYLTRANSFERASE 1; GGTA1
113705
BREAST CANCER, TYPE 1; BRCA1
115200
CARDIOMYOPATHY, DILATED, 1A; CMD1A
143100
HUNTINGTON DISEASE; HD
147450
SUPEROXIDE DISMUTASE 1; SOD1
169100
CHAR SYNDROME
170998
PEROXISOME PROLIFERATOR-ACTIVATED RECEPTOR-ALPHA; PPARA
231300
GLAUCOMA 3, PRIMARY INFANTILE, A; GLC3A
231500
MOVED TO 231300
301000
WISKOTT-ALDRICH SYNDROME; WAS
600393
FLAP STRUCTURE-SPECIFIC ENDONUCLEASE 1; FEN1
600409
PEROXISOME PROLIFERATOR-ACTIVATED RECEPTOR-DELTA; PPARD
601069
ZINC FINGER PROTEIN 239; ZNF239
601411
SARCOGLYCAN, DELTA; SGCD
601487
PEROXISOME PROLIFERATOR-ACTIVATED RECEPTOR-GAMMA; PPARG
603078
CHECKPOINT, S. POMBE, HOMOLOG OF, 1; CHEK1
604065
CALCIUM CHANNEL, VOLTAGE-DEPENDENT, T TYPE, ALPHA-1G SUBUNIT; CACNA1G
606118
HERMANSKY-PUDLAK SYNDROME GENE 3; HPS3
606519
PHACE ASSOCIATION
606665
OPSIN 4; OPN4
Clinical Synopsis for
231500
MOVED TO 231300
February 11, 2002
New Entries:
606681
NUCLEAR RECEPTOR-BINDING Su-var, ENHANCER OF ZESTE, AND TRITHORAX
606682
HERMANSKY-PUDLAK SYNDROME GENE 4; HPS4
606683
FXYD DOMAIN-CONTAINING ION TRANSPORT REGULATOR 6; FXYD6
606684
FXYD DOMAIN-CONTAINING ION TRANSPORT REGULATOR 7; FXYD7
Changed Entries:
116790
CATECHOL-O-METHYLTRANSFERASE; COMT
137750
GLAUCOMA, PRIMARY OPEN ANGLE, JUVENILE-ONSET; JOAG
147870
WINGLESS-TYPE MMTV INTEGRATION SITE FAMILY, MEMBER 2; WNT2
164230
OBSESSIVE-COMPULSIVE DISORDER 1; OCD1
173360
PLASMINOGEN ACTIVATOR INHIBITOR 1; PAI1
176947
ZETA-CHAIN-ASSOCIATED PROTEIN KINASE; ZAP70
179520
RAS-RELATED PROTEIN 1A; RAP1A
202110
ADRENAL HYPERPLASIA, CONGENITAL, DUE TO 17-ALPHA-HYDROXYLASE DEFICIENCY
203300
HERMANSKY-PUDLAK SYNDROME; HPS
208900
ATAXIA-TELANGIECTASIA; AT
209850
AUTISTIC DISORDER
251000
METHYLMALONICACIDURIA DUE TO METHYLMALONIC CoA MUTASE DEFICIENCY
261650
PHOSPHOENOLPYRUVATE CARBOXYKINASE 2, MITOCHONDRIAL; PCK2
261680
PHOSPHOENOLPYRUVATE CARBOXYKINASE 1, SOLUBLE; PCK1
300053
SYNAPTOBREVIN-LIKE 1; SYBL1
300188
TRINUCLEOTIDE REPEAT-CONTAINING GENE 11; TNRC11
309850
MONOAMINE OXIDASE A; MAOA
600085
PROTEIN-TYROSINE KINASE SYK; SYK
600446
ADENOSINE A2B RECEPTOR; ADORA2B
600456
NEUROTROPHIC TYROSINE KINASE, RECEPTOR, TYPE 2; NTRK2
600554
INTERLEUKIN 15; IL15
600665
MELATONIN RECEPTOR 1A; MTNR1A
600807
ASTHMA
601021
NUCLEOPORIN, 98-KD; NUP98
601115
GLUTAMATE RECEPTOR, METABOTROPIC, 3; GRM3
601814
FXYD DOMAIN-CONTAINING ION TRANSPORT REGULATOR 2; FXYD2
602260
PERIOD, DROSOPHILA, HOMOLOG OF; PER1
602359
FXYD DOMAIN-CONTAINING ION TRANSPORT REGULATOR 1; FXYD1
602705
SYNAPSIN III; SYN3
602893
KILLER CELL LECTIN-LIKE RECEPTOR, SUBFAMILY C, MEMBER 4; KLRC4
603023
ZINC FINGER PROTEIN, SUBFAMILY 1A, MEMBER 1; ZNFN1A1
603302
ADENYLATE CYCLASE 9; ADCY9
603348
HYPOXIA-INDUCIBLE FACTOR 1, ALPHA SUBUNIT; HIF1A
603401
ADAPTIN, BETA-3A; AP3B1
603597
SUPPRESSOR OF CYTOKINE SIGNALING 1
603968
POLYMERASE, DNA, ETA; POLH
604099
GLUTAMATE RECEPTOR, METABOTROPIC, 2; GRM2
604126
SUPERVILLIN; SVIL
604982
HERMANSKY-PUDLAK SYNDROME GENE 1; HPS1
604996
FXYD DOMAIN-CONTAINING ION TRANSPORT REGULATOR 3; FXYD3
605474
TOLL-LIKE RECEPTOR 9; TLR9
606118
HERMANSKY-PUDLAK SYNDROME GENE 3; HPS3
606678
TRANSIENT RECEPTOR POTENTIAL CATION CHANNEL, SUBFAMILY M, MEMBER 8;
606681
NUCLEAR RECEPTOR-BINDING Su-var, ENHANCER OF ZESTE, AND TRITHORAX
606683
FXYD DOMAIN-CONTAINING ION TRANSPORT REGULATOR 6; FXYD6
February 8, 2002
Changed Entries:
114480
BREAST CANCER
123900
VILLIN 2; VIL2
126375
DNA METHYLTRANSFERASE 1; DNMT1
141900
HEMOGLOBIN--BETA LOCUS; HBB
142994
HOMEO BOX GENE HB9; HLXB9
159991
MYOGENIC FACTOR 6; MYF6
172420
PHOSPHOLIPASE C, GAMMA-1; PLCG1
176450
CURRARINO SYNDROME
182160
SIALOPHORIN; SPN
228000
FARBER LIPOGRANULOMATOSIS
251000
METHYLMALONICACIDURIA DUE TO METHYLMALONIC CoA MUTASE DEFICIENCY
309845
MOESIN; MSN
601056
BCL2-RELATED PROTEIN A1; BCL2A1
602172
CYTOCHROME P450, SUBFAMILY VIIIB, POLYPEPTIDE 1; CYP8B1
604896
MCKUSICK-KAUFMAN SYNDROME GENE; MKKS
605446
RETINITIS PIGMENTOSA GTPase REGULATOR-INTERACTING PROTEIN; RPGRIP1
605476
PHOSPHOINOSITIDE 3-KINASE ENHANCER
Clinical Synopsis for
273800
THROMBASTHENIA OF GLANZMANN AND NAEGELI
Clinical Synopsis for
303350
MASA SYNDROME
Clinical Synopsis for
601803
PALLISTER-KILLIAN SYNDROME; PKS
February 7, 2002
New Entries:
606665
OPSIN 4; OPN4
Changed Entries:
104219
ALPHA-1D-ADRENERGIC RECEPTOR; ADRA1D
104221
ALPHA-1A-ADRENERGIC RECEPTOR; ADRA1A
104222
MOVED TO 104219
124092
INTERLEUKIN 10; IL10
138160
SOLUTE CARRIER FAMILY 2, MEMBER 2; SLC2A2
150292
LAMININ, GAMMA-2; LAMC2
150310
LAMININ, BETA-3; LAMB3
160781
MYOSIN, LIGHT CHAIN 2, REGULATORY, CARDIAC, SLOW; MYL2
163890
SYNUCLEIN, ALPHA; SNCA
168600
PARKINSON DISEASE; PD
182870
SPECTRIN, BETA, ERYTHROCYTIC; SPTB
185880
VESICLE-ASSOCIATED MEMBRANE PROTEIN 1; VAMP1
186590
SYNTAXIN 1A; STX1A
226650
EPIDERMOLYSIS BULLOSA JUNCTIONALIS, DISENTIS TYPE
227810
FANCONI-BICKEL SYNDROME; FBS
229300
FRIEDREICH ATAXIA 1; FRDA
310200
MUSCULAR DYSTROPHY, PSEUDOHYPERTROPHIC PROGRESSIVE, DUCHENNE AND BECKER
600140
CREB-BINDING PROTEIN; CREBBP
600322
SYNAPTOSOMAL-ASSOCIATED PROTEIN, 25-KD; SNAP25
601179
RAS-RELATED NUCLEAR PROTEIN; RAN
601180
RAN-BINDING PROTEIN 1; RANBP1
601937
NUCLEAR RECEPTOR COACTIVATOR 3; NCOA3
602303
p300/CBP-ASSOCIATED FACTOR; PCAF
602362
GTPase-ACTIVATING PROTEIN, RAN, 1; RANGAP1
604420
HEMATOPOIETICALLY EXPRESSED HOMEO BOX; HHEX
604439
GRB2-ASSOCIATED BINDING PROTEIN 1; GAB1
605242
USHER SYNDROME TYPE IC GENE; USH1C
605417
DICKKOPF, XENOPUS, HOMOLOG OF, 4; DKK4
606203
GRB2-ASSOCIATED BINDING PROTEIN 2; GAB2
606650
GLUTAMATE RECEPTOR, IONOTROPIC, N-METHYL-D-ASPARTATE 3A; GRIN3A
606651
GLUTAMATE RECEPTOR, IONOTROPIC, N-METHYL-D-ASPARTATE 3B; GRIN3B
February 6, 2002
New Entries:
606678
TRANSIENT RECEPTOR POTENTIAL CATION CHANNEL, SUBFAMILY M, MEMBER 8;
606679
TRANSIENT RECEPTOR POTENTIAL CATION CHANNEL, SUBFAMILY V, MEMBER 5;
606680
TRANSIENT RECEPTOR POTENTIAL CATION CHANNEL, SUBFAMILY V, MEMBER 6;
Changed Entries:
105400
AMYOTROPHIC LATERAL SCLEROSIS 1; ALS1
107748
APEX NUCLEASE; APEX
118200
CHARCOT-MARIE-TOOTH DISEASE, TYPE 1B; CMT1B
118220
CHARCOT-MARIE-TOOTH DISEASE, TYPE 1A; CMT1A
119530
OROFACIAL CLEFT 1; OFC1
120140
COLLAGEN, TYPE II, ALPHA-1; COL2A1
134790
FERRITIN LIGHT CHAIN; FTL
137192
GAMMA-AMINOBUTYRIC ACID RECEPTOR, BETA-3; GABRB3
151660
LIPODYSTROPHY, FAMILIAL PARTIAL; FPLD
152430
LONGEVITY
168000
PARAGANGLIOMAS, FAMILIAL NONCHROMAFFIN, 1; PGL1
182870
SPECTRIN, BETA, ERYTHROCYTIC; SPTB
190000
TRANSFERRIN; TF
191342
UBIQUITIN CARBOXYL-TERMINAL ESTERASE L1; UCHL1
213300
JOUBERT SYNDROME 1; JBTS1
220290
DEAFNESS, NEUROSENSORY, AUTOSOMAL RECESSIVE 1; DFNB1
232300
GLYCOGEN STORAGE DISEASE II
250250
CARTILAGE-HAIR HYPOPLASIA; CHH
300276
ECTODYSPLASIN RECEPTOR, X-LINKED
305100
ECTODERMAL DYSPLASIA 1, ANHIDROTIC; ED1
313700
ANDROGEN RECEPTOR; AR
314850
KELL BLOOD GROUP PRECURSOR; XK
600046
ATP-BINDING CASSETTE, SUBFAMILY A, MEMBER 1; ABCA1
600315
TUMOR NECROSIS FACTOR RECEPTOR SUPERFAMILY, MEMBER 4; TNFRSF4
600435
CARDIOTROPHIN 1; CTF1
600886
HYPERFERRITINEMIA-CATARACT SYNDROME
601620
T-BOX 5; TBX5
602026
PHYTANOYL-CoA HYDROXYLASE; PHYH
602322
TELOMERASE RNA COMPONENT; TERC
602690
SUCCINATE DEHYDROGENASE COMPLEX, SUBUNIT D, INTEGRAL MEMBRANE PROTEIN;
603090
UBIQUITIN CARBOXYL-TERMINAL ESTERASE L3; UCHL3
604373
CHECKPOINT KINASE 2, S. POMBE, HOMOLOG OF; CHEK2
604418
GAP JUNCTION PROTEIN, BETA-6; GJB6
604824
KLOTHO; KL
605131
WW DOMAIN-CONTAINING OXIDOREDUCTASE; WWOX
605211
BARH-LIKE 1; BARHL1
606256
STATURE QUANTITATIVE TRAIT LOCUS ON CHROMOSOME 7
February 5, 2002
New Entries:
606674
INFLAMMATORY BOWEL DISEASE 6; IBD6
606675
INFLAMMATORY BOWEL DISEASE 4; IBD4
606676
TRANSIENT RECEPTOR POTENTIAL CATION CHANNEL, SUBFAMILY V, MEMBER 2;
606677
DENDRITIC CELL LECTIN
Changed Entries:
116899
CYCLIN-DEPENDENT KINASE INHIBITOR 1A; CDKN1A
120435
COLON CANCER, FAMILIAL NONPOLYPOSIS, TYPE 1
120436
COLON CANCER, FAMILIAL NONPOLYPOSIS, TYPE 2
125480
MAJOR AFFECTIVE DISORDER 1; MAFD1
137350
GELSOLIN; GSN
141900
HEMOGLOBIN--BETA LOCUS; HBB
143100
HUNTINGTON DISEASE; HD
147683
INTERLEUKIN 13; IL13
147781
INTERLEUKIN 4 RECEPTOR; IL4R
159980
MYOGENIC FACTOR 4; MYOG
160900
DYSTROPHIA MYOTONICA 1
162200
NEUROFIBROMATOSIS, TYPE I; NF1
165161
ONCOGENE JUN-B; JUNB
176807
PROSTATE CANCER
180069
RETINAL PIGMENT EPITHELIUM-SPECIFIC PROTEIN, 65-KD; RPE65
180300
RHEUMATOID ARTHRITIS
180435
RIBONUCLEASE L; RNASEL
188840
TITIN; TTN
190070
V-KI-RAS2 KIRSTEN RAT SARCOMA 2 VIRAL ONCOGENE HOMOLOG; KRAS2
190685
DOWN SYNDROME
242650
PRIMARY CILIARY DYSKINESIA; PCD
244400
KARTAGENER SYNDROME
266600
INFLAMMATORY BOWEL DISEASE 1; IBD1
300237
TRANSCRIPTION ELONGATION FACTOR A-LIKE 1; TCEAL1
300334
TRANSIENT RECEPTOR POTENTIAL CATION CHANNEL, SUBFAMILY C, MEMBER 5;
314670
X INACTIVATION-SPECIFIC TRANSCRIPT; XIST
400000
AZOOSPERMIA FACTOR 2; AZF2
590105
TRANSFER RNA, MITOCHONDRIAL, VALINE; MTTV
600702
SODIUM CHANNEL, VOLTAGE-GATED, TYPE VIII, ALPHA SUBUNIT; SCN8A
600807
ASTHMA
600855
DUAL-SPECIFICITY TYROSINE PHOSPHORYLATION-REGULATED KINASE 1A; DYRK1A
600985
TENASCIN-XB; TNXB
601518
PROSTATE CANCER, HEREDITARY, 1; HPC1
601763
CASPASE 8, APOPTOSIS-RELATED CYSTEINE PROTEASE; CASP8
602343
TRANSIENT RECEPTOR POTENTIAL CATION CHANNEL, SUBFAMILY C, MEMBER 1;
602345
TRANSIENT RECEPTOR POTENTIAL CATION CHANNEL, SUBFAMILY C, MEMBER 3;
602812
H3 HISTONE FAMILY, MEMBER C; H3FC
603335
DYNEIN, AXONEMAL, HEAVY CHAIN 5; DNAH5
603651
TRANSIENT RECEPTOR POTENTIAL CATION CHANNEL, SUBFAMILY C, MEMBER 4;
603652
TRANSIENT RECEPTOR POTENTIAL CATION CHANNEL, SUBFAMILY C, MEMBER 6;
604145
CARDIOMYOPATHY, DILATED, 1G; CMD1G
604396
SET DOMAIN PROTEIN, BIFURCATED, 1; SETDB1
604705
MER TYROSINE KINASE PROTOONCOGENE; MERTK
604774
ANGIOPOIETIN-LIKE 3; ANGPTL3
605377
DYSTROPHIA MYOTONICA PROTEIN KINASE; DMPK
605692
TRANSIENT RECEPTOR POTENTIAL CATION CHANNEL, SUBFAMILY M, MEMBER 7;
606621
ESTROGEN-RELATED RECEPTOR-BETA-LIKE 1; ESRRBL1
606632
ODOR, MALE, WOMEN'S CHOICE OF
February 4, 2002
New Entries:
606673
BETA-UREIDOPROPIONASE; UPB1
Changed Entries:
106150
ANGIOTENSIN I; AGT
115150
CARDIOFACIOCUTANEOUS SYNDROME
126453
DOPAMINE RECEPTOR D5; DRD5
146928
INTERLEUKIN 8 RECEPTOR, BETA; IL8RB
147870
WINGLESS-TYPE MMTV INTEGRATION SITE FAMILY, MEMBER 2; WNT2
162200
NEUROFIBROMATOSIS, TYPE I; NF1
164975
WINGLESS-TYPE MMTV INTEGRATION SITE FAMILY, MEMBER 5A; WNT5A
165330
WINGLESS-TYPE MMTV INTEGRATION SITE FAMILY, MEMBER 3; WNT3
166200
OSTEOGENESIS IMPERFECTA, TYPE I
186973
T-CELL TYROSINE KINASE EMT; EMT
191321
UBIQUITIN A-52-RESIDUE RIBOSOMAL PROTEIN FUSION PRODUCT; UBA52
209850
AUTISTIC DISORDER
210100
BETA-AMINOISOBUTYRIC ACID, URINARY EXCRETION OF
212750
CELIAC DISEASE; CD
213700
CEREBROTENDINOUS XANTHOMATOSIS
215700
CITRULLINEMIA, CLASSIC
219700
CYSTIC FIBROSIS; CF
229050
FOLIC ACID, TRANSPORT DEFECT INVOLVING
261550
PERSISTENT MULLERIAN DUCT SYNDROME, TYPES I AND II; PMDS
264080
PROGESTERONE RESISTANCE; PGR
300248
INHIBITOR OF KAPPA LIGHT POLYPEPTIDE GENE ENHANCER IN B CELLS, KINASE
300291
ECTODERMAL DYSPLASIA, HYPOHIDROTIC, WITH IMMUNE DEFICIENCY
301500
FABRY DISEASE
305100
ECTODERMAL DYSPLASIA 1, ANHIDROTIC; ED1
310500
NIGHT BLINDNESS, CONGENITAL STATIONARY, TYPE 1; CSNB1
311250
ORNITHINE TRANSCARBAMYLASE DEFICIENCY, HYPERAMMONEMIA DUE TO; OTC
600130
APOLIPOPROTEIN B mRNA EDITING ENZYME, CATALYTIC POLYPEPTIDE 1; APOBEC1
600678
MutS, E. COLI, HOMOLOG OF, 6; MSH6
600957
ANTI-MULLERIAN HORMONE; AMH
600983
NUCLEAR RECEPTOR SUBFAMILY 3, GROUP C, MEMBER 2; NR3C2
601098
CHARCOT-MARIE-TOOTH DISEASE, TYPE 1C; CMT1C
601570
WINGLESS-TYPE MMTV INTEGRATION SITE FAMILY, MEMBER 7A; WNT7A
602016
KRUPPEL-LIKE FACTOR 2; KLF2
602096
ALZHEIMER DISEASE, FAMILIAL, TYPE 5
603348
HYPOXIA-INDUCIBLE FACTOR 1, ALPHA SUBUNIT; HIF1A
603349
ENDOTHELIAL PAS DOMAIN PROTEIN 1; EPAS1
603490
WINGLESS-TYPE MMTV INTEGRATION SITE FAMILY, MEMBER 4; WNT4
604663
WINGLESS-TYPE MMTV INTEGRATION SITE FAMILY, MEMBER 6; WNT6
605498
M-PHASE PHOSPHOPROTEIN 1; MPHOSPH1
605923
SRY-BOX 8; SOX8
606352
ALSIN
606361
WINGLESS-TYPE MMTV INTEGRATION SITE FAMILY, MEMBER 5B; WNT5B
606603
EDAR-ASSOCIATED DEATH DOMAIN; EDARADD
606663
LYSYL OXIDASE-LIKE 2; LOXL2
606667
G PROTEIN-COUPLED RECEPTOR 49; GPR49
February 1, 2002
New Entries:
606671
ALL1-FUSED GENE FROM CHROMOSOME 3p21
Changed Entries:
120210
COLLAGEN, TYPE IX, ALPHA-1; COL9A1
126060
DIHYDROFOLATE REDUCTASE; DHFR
126448
MOVED TO 126453
126453
DOPAMINE RECEPTOR D5; DRD5
142702
HISTATIN 3; HTN3
158343
ATP-BINDING CASSETTE, SUBFAMILY C, MEMBER 1; ABCC1
176872
MITOGEN-ACTIVATED PROTEIN KINASE KINASE 1; MAP2K1
601064
ZINC FINGER PROTEIN 36, C3H TYPE-LIKE 1; ZFP36L1
601814
FXYD DOMAIN-CONTAINING ION TRANSPORT REGULATOR 2; FXYD2
602359
FXYD DOMAIN-CONTAINING ION TRANSPORT REGULATOR 1; FXYD1
604996
FXYD DOMAIN-CONTAINING ION TRANSPORT REGULATOR 3; FXYD3
605523
TRANSDUCER OF ERBB2, 1; TOB1
605608
CLAUDIN 14; CLDN14
605706
ANKYRIN REPEAT DOMAIN 3; ANKRD3
606641
BODY MASS INDEX
606642
BODY MASS INDEX QUANTITATIVE TRAIT LOCUS ON CHROMOSOME 7
606643
BODY MASS INDEX QUANTITATIVE TRAIT LOCUS ON CHROMOSOME 13
606669
FXYD DOMAIN-CONTAINING ION TRANSPORT REGULATOR 5; FXYD5
Clinical Synopsis for
602080
PAGET DISEASE OF BONE; PDB
Disclaimer
|
Write to the Help Desk
|
Privacy Policy
NCBI
|
NLM
|
NIH